-
Announcement of the State Food and Drug Administration on the issuance of two supplementary inspection methods for the rosin acid check item in Xiaozhong tablets and the check item of rhubarb glycosides in compound gentian sodium bicarbonate tablets (
Time of Update: 2021-11-14
Supplementary inspection method for rhubarb glycosides inspection items in compound gentian sodium bicarbonate tablets National Medical Products Administration October 12, 2021 National Medical Products Administration 2021 Announcement No.
-
Announcement of the State Food and Drug Administration on the conversion of compound Banlangen Granules into over-the-counter drugs (No. 58 of 2021)
Time of Update: 2021-11-14
The list of varieties (Annex 1) and the template of non-prescription drug instructions (Annex 2) are released together .
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents .
-
Genxi Biotech will announce the results of preclinical research on the treatment of B-cell malignant tumors based on the CD19/CD7 dual-targeting allogeneic CAR-T candidate product (GC502) developed by TruUCAR at the 63rd ASH Annual Meeting
Time of Update: 2021-11-14
Suzhou, Shanghai, China and Palo Alto, California, USA November 4, 2021/PRNewswire/ - Genxi Biotech Group (NASDAQ: GRCL; referred to as "Genxi Bio") is committed to A global clinical-stage biopharmace
-
[FDA] The first C5aR inhibitor comes out!
Time of Update: 2021-11-14
S. FDA announced the approval of ChemoCentryx's oral selective complement 5a receptor (C5aR) inhibitor Tavneos (avacopan) to be marketed, combined with standard therapies to treat severely active antineutrophil cytoplasmic autoantibodies (ANCA) ) Related vasculitis, including granulomatous polyangiitis (GPA) and microscopic polyangiitis (MPA) .
-
Johnson & Johnson, U.S., etc. are all developing the first FcRn-targeted new drug. When will it arrive?
Time of Update: 2021-11-14
In addition, another important research direction in this field is to develop drugs to inhibit the binding of endogenous FcRn and IgG, thereby treating autoimmune diseases driven by autoantibody .
-
National Health Commission: Promote the integration and sharing of resources to implement the functional positioning of county hospitals in the hierarchical diagnosis and treatment system
Time of Update: 2021-11-14
Original title: National Health Commission: Promote the integration and sharing of resources to implement the functional positioning of county hospitals in the hierarchical diagnosis and treatment system The General Office of the National Health Commission issued the "Thousand Counties Project" County Hospital Comprehensive Capacity Improvement Work Plan (2021-2025), striving to achieve the level of tertiary hospital medical service capacity in at least 1,000 county hospitals across the country by 2025.
-
The peptide drug market in my country has further expanded, and these companies are worth recommending
Time of Update: 2021-11-14
As a domestic peptide drug company, Sino Bio has always established its brand with innovative peptide drug pharmaceutical research services and peptide product customized production services, based on the large-scale production and sales of raw materials .
-
Announcement of the State Food and Drug Administration on the conversion of aloe pearl capsule prescription drugs to over-the-counter drugs (No. 115 of 2021)
Time of Update: 2021-11-14
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents .
Variety of non-prescription drug instructions template State Drug Administration September 23, 2021 State Drug Administration Announcement No.
-
TOP10 failed clinical studies in October 2021
Time of Update: 2021-11-14
Phase III study of Canakinumab in the treatment of non-small cell lung cancerNovartis announced on October 25 that the IL-1β inhibitor Canakinumab (canakinumab, ACZ885) combined with pembrolizumab plus platinum dual-drug chemotherapy for the first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) The phase III clinical study (CANOPY-1) failed to achieve the primary endpoints of improving overall survival (OS) and progression-free survival (PFS) .
-
2020 Chinese Hospitals and Chinese Medical Colleges Science and Technology Values (STEM) released
Time of Update: 2021-11-14
( Photo courtesy of the Chinese Academy of Medical Sciences) The picture shows Wang Chen interpreting and releasing the 2020 STEM values for Chinese hospitals/medical colleges .
-
Cumulative savings of about 250 billion yuan!
Time of Update: 2021-11-14
The implementation of centralized procurement has significantly reduced the prices of commonly used drugs for the treatment of common diseases such as high blood pressure, diabetes, hyperlipidemia, cancer, and mental diseases, with an average drop of more than 50%.
-
The large-scale inter-provincial volume procurement has officially started...
Time of Update: 2021-11-14
On November 4, the Guangdong Pharmaceutical Trade Center issued the official version of the "Guangdong Union Amoxicillin and Other 45 Pharmaceutical Groups Procurement Documents", announcing the offic
-
Energy storage biopharmaceutical industry development, Yantai plans to break 200 billion yuan in revenue from its main business in 2023
Time of Update: 2021-11-14
It is understood that the current main business income of Yantai's biomedical industry has exceeded 100 billion yuan, forming a whole industry chain system covering the R&D, manufacturing and circulation of biological drugs, chemical drugs, modern Chinese medicines, and medical devices .
-
The transformation to "intelligent manufacturing" has become the general trend of the development of the pharmaceutical industry!
Time of Update: 2021-11-14
For Hongdou Group's huge investment in building a smart factory project for high-end complex anti-tumor preparations, the industry believes that this is mainly because the pharmaceutical industry is facing the challenge of large-scale production.
-
Yangtze River hits 1 billion injections!
Time of Update: 2021-11-14
Since the beginning of this year, Yangtze River has received 19 injections, covering multiple therapeutic areas such as anti-tumor drugs, anesthetics, and contrast agents .
0 Chinese Drug Evaluation DatabaseSince the beginning of this year, Yangtze River has received 19 injections, covering multiple subcategories such as anti-tumor drugs, anesthetics, and contrast agents.
-
Announcement of the State Food and Drug Administration on the conversion of four drugs including Shenqi Wuweizi Capsules into over-the-counter drugs (No. 100 of 2021)
Time of Update: 2021-11-14
The list of varieties (Annex 1) and the template of non-prescription drug instructions (Annex 2) are released together .
The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents .
-
once a week!
Time of Update: 2021-11-14
ArticleMedicine GuanlanRecently, the Chinese drug clinical trial registration and information disclosure platform showed that Novo Nordisk has launched a trial in China to study how NNC0174-0833 (cagrilintide) can play a role in normal weight, overweight or obese Chinese population .
-
Check the current status of clinical trials of domestic children's anti-tumor drugs!
Time of Update: 2021-11-14
Drug clinical trial registration and information disclosure platform [1]As of November 1, 2021, search with "children", a total of 616 clinical trials were retrieved, 6 of which were indicated as "tumor", and only 2 were related to new anti-tumor drugs (entratinib, larotrectinib) ) .
-
Say no to monopoly APIs!
Time of Update: 2021-11-14
On April 15, the State Municipal Supervision Bureau again notified that a large pharmaceutical company was fined 3% of its sales in 2018, totaling 764 million yuan, for its violations of the anti-monopoly law to implement a monopoly agreement.
-
Generic drugs will remain the focus in the next ten years, and there will still be a broad market
Time of Update: 2021-11-14
Generic drugs have important economic and social benefits in reducing medical expenditures, improving the availability of medicines, and improving the level of medical services . It is understood t
